Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Aqualung Therapeutics Corp.

Clinical trials sponsored by Aqualung Therapeutics Corp., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New antibody aimed at ARDS shows promise in early trial Results expected May 2027 (estimated)

Browse trials soon ready across all sponsors →

Not yet finished but already full! 1

New antibody aimed at ARDS shows promise in early trial

Disease control Ongoing

This study tests a single dose of an antibody called ALT-100 in people with moderate to severe acute respiratory distress syndrome (ARDS), a life-threatening lung condition. The trial involves 15 hospitalized adults and compares the drug to a placebo. The main goal is to check sa…

Phase 2 • Sponsor: Aqualung Therapeutics Corp. • Aim: Disease control

Last updated Jun 27, 2026 07:55 UTC